{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nLncRNA STK4 antisense RNA 1 (STK4-AS1) has emerged as a potential biomarker in multiple cancers, and recent evidence indicates that it plays an important role in the regulation of the cell cycle, thereby modulating the proliferation of osteosarcoma cells. This finding suggests that STK4-AS1 not only serves as a diagnostic indicator but may also represent a functional participant in oncogenic processes, with its ability to influence cell cycle progression marking it as a promising target for therapeutic intervention in cancer treatment."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Weitao Yao, Jingyu Hou, Guoqing Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA STK4 antisense RNA 1 (STK4-AS1) promoted osteosarcoma by inhibiting p53 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-210291"}], "href": "https://doi.org/10.3233/CBM-210291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35912730"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35912730"}]}]}]}